BMS-790052 Chemical Properties

storage temp. 

Store at -20°C

solubility 

Soluble in DMSO > 10 mM

form 

Powder

BMS-790052 Usage And Synthesis

Description

Daclatasvir (BMS-790052; EBP 883) is a first-in-class, highly-selective oral inhibitor of HCV NS5A with EC50 values of 9-50 pM.

Definition

ChEBI: Daclatasvir is a member of the class of biphenyls that is a potent inhibitor of nonstructural protein 5A and is used (as its hydrochloride salt) for treatment of hepatitis C. It has a role as a nonstructural protein 5A inhibitor and an antiviral drug. It is a member of biphenyls, a member of imidazoles, a carbamate ester, a carboxamide and a valine derivative. It is a conjugate base of a daclatasvir(2+).

target

HCV NS5A

BMS-790052(1214735-16-6)Related Product Information

• Sofosbuvir